인공지능(AI) 진단 시장 : 구성요소별, 진단 유형별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

The global artificial intelligence (AI) diagnosis market was valued at US$ 1,110.7 Mn in 2022 and is forecast to reach a value of US$ 5,773.6 Mn by 2030 at a CAGR of 21.2% between 2023 and 2030.

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

• This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

• Global Artificial Intelligence Diagnostics Market, By Component:
  • Software
  • Hardware
  • Services
• Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Neurology
  • Others
• Global Artificial Intelligence Diagnostics Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Vuno Inc.
  • CHC Healthcare Group
  • Aidoc
  • Imbio
  • Alivecor Inc.
  • Digital Diagnostics
  • Retina AI
  • Canon Medical Systems USA
  • Healthy IO
  • Milliman Inc.
  • GE Healthcare
  • Arterys
  • Alivecor Inc.
  • Riverain
  • Lucid Health
  • AI
  • Cardiologs

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Component
  • Market Snapshot, By Service Type
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidence of infectious diseases
  • Concerns about the use of thermometers
  • High demand for Artificial Intelligence (AI) diagnosis devices
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Artificial Intelligence (AI) Diagnosis Market, By Component, 2023-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Hardware
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnosis Market, By Diagnosis Type, 2020-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Pathology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Radiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnosis Market, By Geography, 2023-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2023-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2023-2030,(US$ Mn)

8. Competitive Landscape

• Vuno Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CHC Healthcare Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aidoc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Imbio
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alivecor Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Digital Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Retina AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems USA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Healthy IO
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Milliman Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Arterys
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alivecor Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Riverain
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lucid Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qure.AI
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cardiologs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us